John C. Reed
Sanford Burnham Prebys Medical Discovery Institute · 49 works · 20,464 citations · h-index 38
Top works
- Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
- Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA
- X-linked IAP is a direct inhibitor of cell-death proteases
- Mitochondrial control of cell death
- Guidelines for the use and interpretation of assays for monitoring autophagy
- Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.
- bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs.
- Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells.
- Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene
- The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression.
- Oncogenic potential of bcl-2 demonstrated by gene transfer
- Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1.
- Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma.
- R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism.
- Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenes.
- Programmed Cell Death and Expression of the Protooncogene bcl-2 in Myocytes during Postnatal Maturation of the Heart
- Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
- Interleukin 2 regulates the activity of the lyn protein-tyrosine kinase in a B-cell line.
- Differential effects of Bcl-2 on T and B cells in transgenic mice.
- Structure—Function Analysis of Bcl-2 Family Proteins